Cardiac diastolic dysfunction in renal-transplant recipients is associated with increased circulating Adrenomedullin

Clinical Transplantation

Volumn 20, Issue 3, 2006, Pages 330-335

  Geny, Bernard ^a   Ellero, Bernard ^b   Chakfé, Nabil ^c   Kretz, Jean George ^c   Brandenberger, Gabrielle ^a   Piquard, François ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Service de Chirurgie Generale   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Adrenomedullin; Cardiac function; Diastole; Kidney; Renal transplantation

Indexed keywords

ADRENOMEDULLIN; AZATHIOPRINE; CALCIUM ANTAGONIST; CORTICOSTEROID; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRATE; TACROLIMUS;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE RELAXATION; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; SUPINE POSITION; SYSTOLE;

ADRENOMEDULLIN; ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; CREATININE; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; HEART DISEASES; HEART RATE; HUMANS; KIDNEY TRANSPLANTATION; PEPTIDES; POSTOPERATIVE PERIOD;

EID: 33745080346     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00486.x     Document Type: Article

References (27)

1. Kitamura K, Kangawa K, Kawamoto M et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993: 192: 553.
2. Lopez J, Martinez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol 2002: 221: 1.
3. Tsuruda T, Burnett JC. Adrenomedullin: An autocrine/paracrine factor for cardiorenal protection. Circ Res 2002: 90: 625.
4. Shimosawa T, Shibagaki Y, Ishibashi K et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002: 105: 106.
5. Ishimura K, Nishikimi T, Akimoto K, Ono H, Kangawa K, Matsuoka H. Renoprotective effect of long-term combined treatment with adrenomedullin and omapatrilat in hypertensive rats. J Hypertens 2005: 23: 2287.
6. Nishikimi T, Yoshihara F, Horinaka S et al. Chronic administration of adrenomedullin attenuates transition from left ventricular hypertrophy to heart failure in rats. Hypertension 2003: 42: 1034.
7. Kato J, Tsuruda T, Kita T, Kitamura K, Eto T. Adrenomedullin. A protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005: 25: 2480.
8. Vesely DL. Natriuretic peptides and acute renal failure. Am J Physiol Renal Physiol 2003: 285: F167.
9. Eto T, Kitamura K. Adrenomedullin and its role in renal disease. Nephron 2001: 89: 121.
10. Chao J, Chao L. The role of adrenomedullin in cardiovascular and renal function. Drug News Perspect 2002: 8: 511.
11. Morimoto A, Nishikimi T, Yoshihara F et al. Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats. Hypertension 1999: 33: 1146.
12. Demetriou D, Wenter C, Watschinger B. Vasoactive substances in renal transplantation. Curr Opin Urol 2000: 10: 63.
13. Doutreleau S, Piquard F, Lonsdorfer E et al. Improving exercise capacity, 6 wk training tends to reduce circulating endothelin after heart transplantation. Clin Transplant: 2004: 18: 672. 13
14. Yoshihara F, Horio T, Nakamura S et al. Adrenomedullin reflects cardiac dysfunction, excessive blood volume, and inflammation in hemodialysis patients. Kidney Int 2005: 68: 1355.
15. Geny B, Brandenberger G, Lonsdorfer J, ChakféN, Haberey P, Piquard F. Circulating adrenomedullin is increased after heart transplantation. Cardiovas Res 1999: 41: 731.
16. Piquard F, Charloux A, Mettauer B et al. Exercise-induced increase in circulating adrenomedullin is related to mean blood pressure in heart transplant recipient. J Clin Endocrinol Metab 2000: 85: 2828.
17. Geny B, Ellero B, Charloux A, Brandenberger G, Doutreleau S, Piquard F. Circulating adrenomedullin is increased in relation with increased creatinine and atrial natriuretic peptide in liver-transplant recipients. Regul Pept 2003: 114: 61.
18. Tsuruda T, Jougasaki M, Boerrigter G et al. Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart. Regul Pept 2003: 112: 161.
19. Geny B, Doutreleau S, Elero B et al. Circulating adrenomedullin is increased after renal transplantation. Transplant Proc 2001: 33: 3396.
20. Aakhus S, Dahl K, Wideroe TE. Cardiovascular disease in stable renal transplant patients in Norway: Morbidity and mortality during a 5-yr follow-up. Clin Transplant 2004: 18: 596.
21. De Lima JJ, Vieira ML, Viviani LF et al. Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant 2002: 17: 645.
22. Yu CM, Cheung BM, Leung R, Wang Q, Lai WH, Lau CP. Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction. Heart 2001: 86: 155.
23. Nishimori T, Tsujino M, Sato K, Imai T, Marumo F, Hirata Y. Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes. J Mol Cell Cardiol 1997: 29: 2125.
24. Piquard F, Richard R, Hardy H et al. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart-transplant patients. J Appl Physiol 2002: 93: 569.
25. Geny B, Hardy H, Lampert E et al. Short term effect of cyclosporine on circulating adrenomedullin after heart transplantation. J Thorac Cardiovasc Surg 1999: 117: 391.
26. Nishikimi T, Kitamura K, Saito Y et al. Clinical studies for the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994: 24: 600.
27. Nakamura R, Kato J, Kitamura K et al. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats. Circulation 2004: 27: 426.